Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to Humans

Annual Review of Medicine

Volumn 54, Issue , 2003, Pages 131-152

  Hursting, Stephen D ^a   Lavigne, Jackie A ^a   Berrigan, David ^a   Perkins, Susan N ^a   Barrett, J Carl ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Carcinogenesis; Insulin like growth factor 1; Reactive oxygen species

Indexed keywords

DAIDZEIN; FENRETINIDE; GENISTEIN; KAEMPFEROL; OCTREOTIDE; QUERCETIN; RETINOIC ACID; SOMATOMEDIN C; TAMOXIFEN; REACTIVE OXYGEN METABOLITE;

AGING; ANIMAL TISSUE; CALORIC RESTRICTION; CANCER PREVENTION; CARCINOGENESIS; CHRONIC DISEASE; GENE EXPRESSION; HEALTH PROMOTION; HUMAN; LIFESPAN; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; ANIMAL; APOPTOSIS; METABOLISM; NEOPLASM; PHYSIOLOGY; RISK;

AGING; ANIMALS; APOPTOSIS; CALORIC RESTRICTION; HEALTH PROMOTION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS; REACTIVE OXYGEN SPECIES; RISK;

EID: 0013072999     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.54.101601.152156     Document Type: Review

References (122)

1. Kritchevsky D. 1993. Colorectal cancer: the role of dietary fat and caloric restriction. Mutat. Res. 290:63-70
2. McCay CM, Crowell MF. 1934. Prolonging the life span. Sci. Mon. 39:405-14
3. Kritchevsky D. 1993. Undernutrition and chronic disease: cancer. Proc. Nutr. Soc. 52:39-47
4. McCay CM, Crowell MF, Maynard LA. 1935. The effect of retarded growth upon the length of life span and upon the ultimate body size. J. Nutr. 10:63-79
5. Tannenbaum A. 1944. The dependence of the genesis of induced skin tumors on the caloric intake during different stages of carcinogenesis. Cancer Res. 4:673-79
6. Tannenbaum A. 1940. The initiation and growth of tumors. Introduction. I. Effects of underfeeding. Am. J. Cancer 38:335-50
7. Weindruch R, Walford RL. 1988. The Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: Charles C. Thomas
8. Hursting SD, Kari FW. 1999. The anticarcinogenic effects of dietary restriction: mechanisms and future directions. Mutat. Res. 443:235-49
9. Berrigan D, Perkins SN, Haines DC, Hursting SD. 2002. Adult-onset calorie restriction and fasting delay spontaneous tumorigenesis in p53-deficient mice. Carcinogenesis 23:817-22
10. Kritchevsky D. 1999. Caloric restriction and experimental carcinogenesis. Toxicol. Sci. 52:13-16
11. Thompson HJ, Zhu Z, Jiang W. 2002. Protection against cancer by energy restriction: all experimental approaches are not equal. J. Nutr. 132:1047-49
12. Vainio H, Bianchini F, eds. 2002. In Weight Control and Physical Activity. IARC Handbooks of Cancer Prevention 6, pp. 1-23. Lyon, France: IARC Press
13. NHLBI Obesity Education Initiative Expert Panel. 1998. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. NIH Pub. No. 98-4083. http://rover2.nhlbi.nih.gov/ guidelines/obesity/obhome.htm
14. Hart RW, Keenan K, Turturro A, et al. 1995. Caloric restriction and toxicity. Fundam. Appl. Toxicol. 25:184-95
15. Fishbein L. 1991. Biological Effects of Dietary Restriction. Berlin: Springer-Verlag
16. Frame LT, Hart RW, Leakey JE. 1998. Caloric restriction as a mechanism mediating resistance to environmental disease. Environ. Health. Perspect. 106(Suppl. 1): 313-24
17. Masoro EJ. 1993. Dietary restriction and aging. J. Am. Geriatr. Soc. 41:994-99
18. Kari FW, Dunn SE, French JE, Barrett JC. 1999. Roles for insulin-like growth factor - 1 in mediating the anticarcinogenic effects of caloric restriction. J. Nutr. Health Aging 3:92-101
19. Roth GS, Ingram DK, Lane MA. 2001. Caloric restriction in primates and relevance to humans. Ann. NY Acad. Sci. 928:305-15
20. Pinney DO, Stephens DF, Pope LS. 1972. Lifetime effects of winter supplemental feed level and age at first parturition on range beef cows. J. Animal Sci. 34:1067-74
21. Defossez PA, Lin SJ, McNabb DS. 2001. Sound silencing: the Sir2 protein and cellular senescence. BioEssays 23:327-32
22. Kealy RD, Lawler DE, Ballam JM, et al. 2002. Effects of diet restriction on life span and age-related changes in dogs. J. Am. Vet. Med. Assoc. 220:1315-20
23. Hursting SD, Lubet RA. 2002. The utility of transgenic mouse models for cancer prevention research. In Tumor Models and Cancer Research, pp. 263-274. Totowa, NJ: Humana
24. Tannenbaum A. 1942. The genesis and growth of tumors. II. Effects of caloric restriction per se. Cancer Res. 2:460-64
25. Andreou KK, Morgan PR. 1981. Effect of dietary restriction on induced hamster cheek pouch carcinogenesis. Arch. Oral Biol. 26:525-31
26. Boissonneault GA, Elson CE, Pariza MW. 1986. Net energy effects of dietary fat on chemically induced mammary carcinogenesis in F344 rats. J. Natl. Cancer Inst. 76:335-38
27. Lagopoulos L, Stalder R. 1987. The influence of food intake on the development of diethylnitrosamine-induced liver tumours in mice. Carcinogenesis 8:33-37
28. Dunn SE, Kari FW, French J, et al. 1997. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 57:4667-72
29. Gross L, Dreyfuss Y. 1990. Prevention of spontaneous and radiation-induced tumors in rats by reduction of food intake. Proc. Natl. Acad. Sci. USA 87:6795-97
30. Gross L, Dreyfuss Y. 1984. Reduction in the incidence of radiation-induced tumors in rats after restriction of food intake. Proc. Natl. Acad. Sci. USA 81:7596-98
31. Roth GS, Ingram DK, Lane MA. 1999. Calorie restriction in primates: Will it work and how will we know? J. Am. Geriatr. Soc. 47:896-903
32. Temizhan A, Tandogan I, Donderici O, Demirbas B. 2000. The effects of Ramadan fasting on blood lipid levels. Am. J. Med. 109:341-42
33. Kagawa Y. 1978. Impact of Westernization on the nutrition of Japanese: changes in physique, cancer, longevity and centenarians. Prev. Med. 7:205-17
34. van Noord PA, Kaaks R. 1991. The effect of wartime conditions and the 1944-45 "Dutch famine" on recalled menarcheal age in participants of the DOM breast cancer screening project. Ann. Hum. Biol. 18:57-70
35. Walford RL, Harris SB, Gunion MW. 1992. The calorically restricted low-fat nutrient-dense diet in Biosphere 2 significantly lowers blood glucose, total leukocyte count, cholesterol, and blood pressure in humans. Proc. Natl. Acad. Sci. USA 89:11533-37
36. Velthuis-te Wierik EJ, van den Berg H, Schaafsma G, et al. 1994. Energy restriction, a useful intervention to retard human ageing? Results of a feasibility study. Eur. J. Clin. Nutr. 48:138-48
37. Lane MA, Black A, Handy A, et al. 2001. Caloric restriction in primates. Ann. NY Acad. Sci. 928:287-95
38. Lok E, Nera EA, Iverson F, et al. 1988. Dietary restriction, cell proliferation and carcinogenesis: a preliminary study. Cancer Lett. 38:249-55
39. Hursting SD, Perkins SN, Phang JM. 1994. Calorie restriction delays spontaneous tumorigenesis in p53-knockout transgenic mice. Proc. Natl. Acad. Sci. USA 91:7036-40
40. Lev-Ran A. 1998. Mitogenic factors accelerate later-age diseases: insulin as a paradigm. Mech. Ageing Dev. 102:95-113
41. Thompson HJ, Strange R, Schedin PJ. 1992. Apoptosis in the genesis and prevention of cancer. Cancer Epidemiol. Biomarkers Prev. 1:597-602
42. Grasl-Kraupp B, Bursch W, Ruttkay-Nedecky B, et al. 1994. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. USA 91:9995-99
43. James SJ, Muskhelishvili L. 1994. Rates of apoptosis and proliferation vary with caloric intake and may influence incidence of spontaneous hepatoma in C57BL/6 x C3H F1 mice. Cancer Res. 54:5508-10
44. Poetschke HL, Klug DB, Perkins SN, et al. 2000. Effects of calorie restriction on thymocyte growth, death and maturation. Carcinogenesis 21:1959-64
45. Le Roith D, Bondy C, Yakar S, et al. 2001. The somatomedin hypothesis: 2001. Endocr. Rev. 22:53-74
46. Yu H, Rohan T. 2000. Role of the insulin-like growth factor family in cancer development and progression. J. Natl. Cancer Inst. 92:1472-89
47. Resnicoff M, Abraham D, Yutanawiboonchai W, et al. 1995. The insulin-like growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res. 55:2463-69
48. Dunn SE, Ehrlich M, Sharp NJ, et al. 1998. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res. 58:3353-61
49. Resnicoff M, Coppola D, Sell C, et al. 1994. Growth inhibition of human melanoma cells in nude mice by antisense strategies to the type 1 insulin-like growth factor receptor. Cancer Res. 54:4848-50
50. D'Ambrosio C, Ferber A, Resnicoff M, Baserga R. 1996. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res. 56:4013-20
51. Macaulay VM. 1992. Insulin-like growth factors and cancer. Br. J. Cancer 65:311-20
52. LeRoith D, Baserga R, Helman L, Roberts CT Jr. 1995. Insulin-like growth factors and cancer. Ann. Intern. Med. 122:54-59
53. 2) is associated with significant changes in the expression and secretion of insulin-like growth factor (IGF) IGF-II and IGF binding protein-4: role of IGF-II. Endocrinology 137:1764-74
54. Buckbinder L, Talbott R, Velasco-Miguel S, et al. 1995. Induction of the growth inhibitor IGF-binding protein 3 by p53. Nature 377:646-49
55. Takahashi K, Suzuki K. 1993. Association of insulin-like growth-factor-I-induced DNA synthesis with phosphorylation and nuclear exclusion of p53 in human breast cancer MCF-7 cells. Int. J. Cancer 55:453-58
56. Gems D, Partridge L. 2001. Insulin/IGF signalling and ageing: seeing the bigger picture. Curr. Opin. Genet. Dev. 11:287-92
57. Clancy DJ, Gems D, Harshman LG, et al. 2001. Extension of life-span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292:104-6
58. Tatar M, Kopelman A, Epstein D, et al. 2001. A mutant Drosophila insulin receptor homolog that extends life-span and impairs neuroendocrine function. Science 292:107-10
59. Murakami S, Johnson TE. 1996. A genetic pathway conferring life extension and resistance to UV stress in Caenorhabditis elegans. Genetics 143:1207-18
60. Barsyte D, Lovejoy DA, Lithgow GJ. 2001. Longevity and heavy metal resistance in daf-2 and age-1 long-lived mutants of Caenorhabditis elegans. FASEB J. 15:627-34
61. Murakami S, Johnson TE. 1998. Life extension and stress resistance in Caenorhabditis elegans modulated by the tkr-1 gene. Curr. Biol. 8:1091-94
62. Murakami S, Johnson TE. 2001. The OLD-1 positive regulator of longevity and stress resistance is under DAF-16 regulation in Caenorhabditis elegans. Curr. Biol. 11:1517-23
63. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE. 2001. Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc. Natl. Acad. Sci. USA 98:6736-41
64. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ. 2000. Assessment of growth parameters and life span of GHR/BP gene-disrupted mice. Endocrinology 141:2608-13
65. dw can increase life span in mice. Mech. Ageing Dev. 123:121-30
66. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. 1996. Dwarf mice and the ageing process. Nature 384:33
67. Anisimov VN. 2001. Mutant and genetically modified mice as models for studying the relationship between aging and carcinogenesis. Mech. Ageing Dev. 122:1221-55
68. DiGiovanni J, Bol DK, Wilker E, et al. 2000. Constitutive expression of insulin-like growth factor-1 in epidermal basal cells of transgenic mice leads to spontaneous tumor promotion. Cancer Res. 60:1561-70
69. DiGiovanni J, Kiguchi K, Frijhoff A, et al. 2000. Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice. Proc. Natl. Acad. Sci. USA 97:3455-60
70. Hursting SD, Lavigne JA, Perkins SN, et al. 2002. Susceptibility of BK5.IGF-1 transgenic mice to p-cresidine-induced bladder carcinogenesis. In Proc. Annu. Meet. Am. Assoc. Cancer Res., p. 168. Linthicum, MD: Cadmus Prof. Commun.
71. Hankinson SE, Willett WC, Colditz GA, et al. 1998. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-96
72. Chan JM, Stampfer MJ, Giovannucci E, et al. 1998. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-66
73. Wolk A, Mantzoros CS, Andersson SO, et al. 1998. Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study. J. Natl. Cancer Inst. 90:911-15
74. Schaefer C, Friedman GD, Quesenberry CP Jr, et al. 1998. IGF-1 and prostate cancer. Science 282:199
75. Yu H, Spitz MR, Mistry J, et al. 1999. Plasma levels of insulin-like growth factor-I and lung cancer risk: a case-control analysis. J. Natl. Cancer Inst. 91:151-56
76. Ma J, Pollak MN, Giovannucci E, et al. 1999. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J. Natl. Cancer Inst. 91:620-25
77. Giovannucci E, Pollak MN, Platz EA, et al. 2000. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol. Biomarkers Prev. 9:345-49
78. Petridou E, Dessypris N, Spanos E, et al. 1999. Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int. J. Cancer 80:494-96
79. Hursting SD, Switzer BR, French JE, Kari FW. 1993. The growth hormone: insulin-like growth factor 1 axis is a mediator of diet restriction-induced inhibition of mononuclear cell leukemia in Fischer rats. Cancer Res. 53:2750-57
80. Ruggeri BA, Klurfeld DM, Kritchevsky D, Furlanetto RW. 1989. Caloric restriction and 7,12-dimethylbenz(a)-anthracene-induced mammary tumor growth in rats: alterations in circulating insulin, insulin-like growth factors I and II, and epidermal growth factor. Cancer Res. 49:4130-34
81. Sohal RS, Weindruch R. 1996. Oxidative stress, caloric restriction, and aging. Science 273:59-63
82. Ames BN, Shigenaga MK, Hagen TM. 1993. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA 90:7915-22
83. Lin YJ, Seroude L, Benzer S. 1998. Extended life-span and stress resistance in the Drosophila mutant methuselah. Science 282:943-46
84. shc adaptor protein controls oxidative stress response and life span in mammals. Nature 402:309-13
85. Brown-Borg HM, Rakoczy SG, Romanick MA, Kennedy MA. 2002. Effects of growth hormone and insulin-like growth factor-1 on hepatocyte antioxidative enzymes. Exp. Biol. Med. (Maywood) 227:94-104
86. Youngman LD, Park JY, Ames BN. 1992. Protein oxidation associated with aging is reduced by dietary restriction of protein or calories. Proc. Natl. Acad. Sci. USA 89:9112-16
87. Mei JJ, Hursting SD, Perkins SN, Phang JM. 1998. p53-independent inhibition of nitric oxide generation by cancer preventive interventions in ex vivo mouse peritoneal macrophages. Cancer Lett. 129:191-97
88. Lee CK, Klopp RG, Weindruch R, Prolla TA. 1999. Gene expression profile of aging and its retardation by caloric restriction. Science 285:1390-93
89. Lee CK, Weindruch R, Prolla TA. 2000. Gene-expression profile of the ageing brain in mice. Nat. Genet. 25:294-97
90. Weindruch R, Kayo T, Lee CK, Prolla TA. 2002. Gene expression profiling of aging using DNA microarrays. Mech. Ageing Dev. 123:177-93
91. Pletcher SD, Macdonald SJ, Marguerie R, et al. 2002. Genome-wide transcript profiles in aging and calorically restricted Drosophila melanogaster. Curr. Biol. 12:712-23
92. Cao SX, Dhahbi JM, Mote PL, Spindler SR. 2001. Genomic profiling of short-and long-term caloric restriction effects in the liver of aging mice. Proc. Natl. Acad. Sci. USA 98:10630-35
93. Kayo T, Allison DB, Weindruch R, Prolla TA. 2001. Influences of aging and caloric restriction on the transcriptional profile of skeletal muscle from rhesus monkeys. Proc. Natl. Acad. Sci. USA 98:5093-98
94. McGuire MT, Wing RR, Klem ML, Hill JO. 1999. Behavioral strategies of individuals who have maintained long-term weight losses. Obes. Res. 7:334-41
95. Vogt A, Rice RL, Settineri CE, et al. 1998. Disruption of insulin-like growth factor-1 signaling and down-regulation of cdc2 by SC-alphaalphadelta9, a novel small molecule antisignaling agent identified in a targeted array library. J. Pharmacol. Exp. Ther. 287:806-13
96. Chen C, Zhu YF, Liu XJ, et al. 2001. Discovery of a series of nonpeptide small molecules that inhibit the binding of insulin-like growth factor (IGF) to IGF-binding proteins. J. Med. Chem. 44:4001-10
97. Scotlandi K, Maini C, Manara MC, et al. 2002. Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells. Cancer Gene Ther. 9:296-307
98. Granerus M, Engstrom W. 2001. Effects of insulin-like growth factor-binding protein 2 and an IGF-type I receptor-blocking antibody on apoptosis in human teratocarcinoma cells in vitro. Cell Biol. Int. 25:825-28
99. Friedl A, Jordan VC, Pollak M. 1993. Suppression of serum insulin-like growth factor-1 levels in breast cancer patients during adjuvant tamoxifen therapy. Eur. J. Cancer 29A:1368-72
100. Shojamanesh H, Gibril F, Louie A, et al. 2002. Prospective study of the antitumor efficacy of long-term octreotide treatment in patients with progressive metastatic gastrinoma. Cancer 94:331-43
101. Decensi A, Johansson H, Miceli R, et al. 2001. Long-term effects of fenretinide, a retinoic acid derivative, on the insulin-like growth factor system in women with early breast cancer. Cancer Epidemiol. Biomarkers Prev. 10:1047-53
102. Zujewski J. 2002. Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention. Environ. Mol. Mutagen. 39:264-70
103. Eliakim A, Brasel JA, Mohan S, et al. 1996. Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females. J. Clin. Endocrinol. Metab. 81: 3986-92
104. Smith AT, Clemmons DR, Underwood LE, et al. 1987. The effect of exercise on plasma somatomedin-C/insulin-like growth factor I concentrations. Metabolism 36:533-37
105. Nicklas BJ, Ryan AJ, Treuth MM, et al. 1995. Testosterone, growth hormone and IGF-I responses to acute and chronic resistive exercise in men aged 55-70 years. Int. J. Sports Med. 16:445-50
106. Rudman D, Feller AG, Nagraj HS, et al. 1990. Effects of human growth hormone in men over 60 years old. N. Engl. J. Med. 323:1-6
107. Rosen CJ, Donahue LR. 1998. Insulin-like growth factors and bone: the osteoporosis connection revisited. Proc. Soc. Exp. Biol. Med. 219:1-7
108. Ferguson VL, Greenberg AR, Bateman TA, et al. 1999. The effects of age and dietary restriction without nutritional supplementation on whole bone structural properties in C57BL/6J mice. Biomed. Sci. Instrum. 35:85-91
109. Sanderson JP, Binkley N, Roecker EB, et al. 1997. Influence of fat intake and caloric restriction on bone in aging male rats. J. Gerontol. A Biol. Sci. Med. Sci. 52:B20-25
110. Buist DS, LaCroix AZ, Barlow WE, et al. 2001. Bone mineral density and endogenous hormones and risk of breast cancer in postmenopausal women (United States). Cancer Causes Control 12:213-22
111. Cauley JA, Lucas FL, Kuller LH, et al. 1996. Bone mineral density and risk of breast cancer in older women: the study of osteoporotic fractures. Study of Osteoporotic Fractures Research Group. JAMA 276:1404-8
112. Zhang Y, Kiel DP, Kreger BE, et al. 1997. Bone mass and the risk of breast cancer among postmenopausal women. N. Engl. J. Med. 336:611-17
113. Birt DF, Yaktine A, Duysen E. 1999. Glucocorticoid mediation of dietary energy restriction inhibition of mouse skin carcinogenesis. J. Nutr. 129:571S-4S
114. Zhang Y, Leibel R. 1998. Molecular physiology of leptin and its receptor. Growth Genet. Horm. 14:17-35
115. Loffreda S, Yang SQ, Lin HZ, et al. 1998. Leptin regulates proinflammatory immune responses. FASEB J. 12:57-65
116. Chang S, Hursting SD, Contois JH, et al. 2001. Leptin and prostate cancer. Prostate 46:62-67
117. Willett WC. 2002. Balancing life-style and genomics research for disease prevention. Science 296:695-98
118. Knowler WC, Barrett-Connor E, Fowler SE, et al. 2002. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 346:393-403
119. Hursting SD, Perkins SN, Brown CC, et al. 1997. Calorie restriction induces a p53-independent delay of spontaneous carcinogenesis in p53-deflcient and wild-type mice. Cancer Res. 57:2843-46
120. Weindruch R, Walford RL, Fligiel S, Guthrie D. 1986. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake. J. Nutr. 116:641-54
121. Berg BN, Simms HS. 1961. Nutrition and longevity in the rat. III. Food restriction beyond 800 days. J. Nutr. 74:23-32
122. Yu BP, Masoro EJ, Murata I, et al. 1982. Life span study of SPF Fischer 344 male rats fed ad libitum or restricted diets: longevity, growth, lean body mass and disease. J. Gerontol. 37:130-41